Let’s move from ‘Volume’ to the “Value” leadership to capture the global drug market. It is time to gather information from the world’s leading research, innovation and innovation practices and develop our models that focus on speeding up production to meet domestic demand and expand our global environment. The Minister of Chemical, Fertilizer and Family Health and Family Welfare, Dr. Mansukh Mandaviya encouraged champions and leaders of the pharmaceutical industry during the collaboration with the Indian Pharmaceutical Alliance. The purpose of the meeting was to discuss Pharma Vision 2047 of India and a road map of the Indian pharmaceutical industry. The session discussed the current state of the pharmaceutical industry in India, the significant efforts taken by the Government over the past few years and the co-operative measures that will help India achieve this vision.
Echoing the Prime Minister’s view of acquiring Aatmanirbharta in all sectors, Dr. Mansukh Mandaviya aims to make the medical profession jump on the bandwagon of growth for years to come. He said “we already have the” human strength and productivity “needed and Indian companies today are in a position to occupy the top positions in the world. worldwide based on the number also, he stressed. “We have always believed in supporting the world while balancing our domestic needs. It was a time of catastrophe when the world turned to India, we brought it. This has led to global awareness of power in India and we must now take this opportunity to the next level “Discover and Make in India”.
Dr Mandaviya emphasized the importance of long-term policies that provide stability in the industry. Emphasizing that the Government is committed to supporting Pharma Companies with Industrial Agreement policies and investors promoting the ecosystem, he said: “This Government believes in taking a holistic approach. Our policies are based on comprehensive and comprehensive stakeholder consultation that provide the basis for a comprehensive, long-term and healthy policy process ”.
At the same time, he added that “we need to move forward with Pharma Industry at the forefront of leading and promoting its models and programs in increasing production capacity, investing in new technologies and focusing on research and development. Government will strengthen the sector by improving policies and operational programs such as PLI that support quality research ”. Apart from the policy, Drs. Mandaviya also focused on investment in research and development, effective manufacturing skills and the creation of more innovative opportunities that are needed for an hour now. He hoped that with these measures we would be able to build a vibrant ecosystem for the sector.
Ms S Aparna, Secretary, Department of Medicine, said the Government of India continues to work towards achieving our goals in the field of medicine, ranging from various industry-related programs to focusing on access, innovation, quality and accessibility to help achieve India. Pharma Vision 2047. ” He added that they face the problem of policy stability, facilitating change and freedom of control to increase productivity and ensure quality testing. Government also encourages investment in research and development (R&D), exports and digital, to promote the implementation of new start-up and business initiatives. He added that the review process was expedited and accountability was ensured through the construction of appropriate channels. Focusing on these areas will help us grow in the pharmaceutical industry and will boost confidence in the field.
The Indian Pharmaceutical Alliance discussed and highlighted various issues such as policy stability, innovation, regulatory framework and facilitation that includes transparency and accountability, CDSCO review process, regular monitoring of implementation, pricing and associated controls, investment in targeted infrastructure to give impetus. research on innovation, expansion of chemical production and API to increase exports, digitalization to maximize information sharing, use of medical education and increased access to quality health care, and how to recommend “Brand India” by investing in the beginning. -inclining and collaborating with education to get the best possible results.
